News

Ursamin CEO and Founder Joins Nashville Entrepreneur Center 2024 Project Healthcare Cohort

Project Healthcare Program Shines with Record of Fostering Innovation in HealthcareFAYETTEVILLE, NY / ACCESSWIRE / January 25, 2024 / Ursamin,…

7 months ago

Caspar.AI Launches Contactless Vitals & Real-time Bed Monitoring Solutions with Arcadia, Shellpoint, and Melur Meadows

Revolutionizing remote healthcare with Ambient AIPALO ALTO, CA / ACCESSWIRE / January 25, 2024 / Caspar.AI, an innovator in AI-driven…

7 months ago

Shifox Re-Brands as Alopex and Announces Completion of Investment Round

Completion of Recent Funding Round Allows Alopex to Expand Staff and Enhance TechnologyLAS VEGAS, NV / ACCESSWIRE / January 25,…

7 months ago

PMD Informs About the Record Date and Procedure of Reverse Split of Shares

STOCKHOLM, SWEDEN / ACCESSWIRE / January 25, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) At PMD's General Meeting on December 29,…

7 months ago

Castellum Announces Pricing of $2.7 Million Registered Direct Offering

Castellum Announces Pricing of $2.7 Million Registered Direct Offering Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and…

7 months ago

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a…

7 months ago

Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.

Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase…

7 months ago

Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company

WARRINGTON, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company…

7 months ago

NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program

Project to benefit from Scorpius’ comprehensive services in process development, bioanalysis, and cGMP manufacturingDURHAM, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE)…

7 months ago

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical…

7 months ago